INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹706 Cr | ₹684 Cr | ₹688 Cr | ₹154 Cr | ₹100 Cr |
What is the latest Total Non-Current Assets ratio of INDEGENE ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹706 Cr |
| Mar2024 | ₹684 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹154 Cr |
| Mar2021 | ₹100 Cr |
How is Total Non-Current Assets of INDEGENE Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹706 Cr | 3.23 | |
| Mar2024 | ₹684 Cr | -0.60 | |
| Mar2023 | ₹688 Cr | 345.98 | |
| Mar2022 | ₹154 Cr | 54.28 | |
| Mar2021 | ₹100 Cr | - | |
Compare Total Non-Current Assets of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,434.6 Cr | -1.1% | -8.6% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -1.1% |
-8.6% |
-29.3% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses